Pharmaceuticals

Avicena’s in-depth understanding of how to modulate cellular energy levels has specific applications in the treatment of a number of debilitating neurological and neuromuscular diseases, including ALS (Lou Gehrig’s disease), Huntington’s disease and Parkinson’s disease. As such, the company is collaborating with renowned clinicians at leading academic institutions to leverage its proprietary cellular energy modulation and cellular energy transfer platforms for the development of much needed therapeutics. Avicena’s drug candidates are designed to prolong cell life and, in turn, ease the symptoms of a disease and/or slow the disease’s progression.